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The subject oftrans fatty acids has stimulated considerable discus-
sion. Consequently, we have invitedfour authorities in the field to
submit commentaries on the supplement Trans fatty acids and
coronary heart disease risk that follows later in this issue. This
procedure will be followed when a supplement or an article de-
mands special attention.
Commentary on the supplement Trans fatty acids and
coronaty heart disease risk
Martijn B Katan
The health effects of partially hydrogenated oils have been
debated for many years. As a result, such fats have been
thoroughly scrutinized, but no toxic effects were detected even
after massive doses were fed to various animal species for
several generations.
Until recently the effect of trans fatty acids on serum cho-
lesterol was equivocal: of the three studies that met certain
quality criteria (1), two found effects of trans fatty acids
intermediate between those of cis unsaturates and saturated
fatty acids and one found no difference from cis monounsat-
urates. The issue was not pressing because concentrations of
trans fatty acids in the diet are fairly low. However, we decided
to reinvestigate the question. We found that the effect of trans
monounsaturated fatty acids on total cholesterol was indeed
intermediate between that of cis monounsaturates and satu-
rates, but that this masked more drastic effects on high-density-
lipoprotein (HDL) concentrations, which decreased, and on
low-density-lipoprotein (LDL) concentrations, which increased
(2). Several groups have investigated the matter since then
(3-6).
PRESENT DATA ON TRANS FATTY ACIDS, LDL,
AND HDL
Figure 1 summarizes the changes in LDL and HDL choles-
terol that occurred when trans fatty acids replaced carbohy-
drates in recent trials. Actually, cis monounsaturates were used
in the studies as a control treatment but we recalculated the raw
data to a carbohydrate-rich diet (1) to ease comparison with the
animal data in the International Life Sciences Institute (ILSI)
report (7).
The figure shows that relative to carbohydrates trans fatty
acids uniformly raised LDL cholesterol in humans. This is in
contrast with the animal data in the ILSI report: in hamsters,
trans fatty acids had a neutral effect on plasma LDL metabo-
lism and concentration. Even replacement of saturated fatty
acids by trans fatty acids does not always lower LDL in
humans; in two studies (4, 6), LDL concentrations were the
same with high-trans and high-saturated fatty acid diets, espe-
cially after minor differences in other fatty acids were corrected
for. This is not to say that partially hydrogenated oils produce
the same LDL concentration as do butter or tropical oils; the
sum of saturated plus trans fatty acids in butter and tropical oils
is much higher than that in products such as marganines.
Therefore, an exchange of margarine for butter will still
decrease LDL concentrations.
The effect of trans fatty acids on HDL shown in Figure 1 is
small, but carbohydrates themselves lower HDL relative to fats
(1). When trans fatty acids replace other fatty acids rather than
carbohydrates the effect on HDL is sometimes quite marked,
even though it varies between studies (8). I cannot agree with
the authors of the ILSI report that these effects on HDL could
be due to random variation. On the contrary, variability might
obscure effects on HDL in studies with small numbers of
subjects or low doses. I am also more concerned than the
authors of the report about adverse effects of lowering HDL. In
a recent angiographic trial, drug-induced decreases in HDL
were significantly correlated with decreases in lumen volume
of the femoral artery (9). In other trials, drug-induced increases
in HDL reduced cardiovascular risk. When combined with the
epidemiologic (10), genetic, and metabolic data on HDL this
argues for some prudence.
LIPOPROTEIN(A)
Several trials have now reported that trans fatty acids raise
serum lipoprotein(a) concentrations. The ILSI report argues
that this may involve confounding through random fluctuations
and assay artifacts; however, in a randomized, controlled trial,
assay bias is equal for both treatments and will be eliminated.
I From the Department of Human Nutrition, Wageningen Agricultural
University, the Netherlands.
2 Reprints not available. Address correspondence to MB Katan, Depart-
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FIGURE 1. Effects of monounsaturated trans fatty acids (trans-18:1)
on lipoprotein cholesterol concentrations relative to carbohydrates (circles,
LDL; squares, HDL). Data are derived from six dietary comparisons
between trans monounsaturates and other fatty acids, largely cis unsatur-
ated fatty acids: Judd et al (6), Lichtenstein et al (5), Nestel et al (4), Zock
and Katan (3), and Mensink and Katan (2). Values were recalculated to a
comparison with carbohydrates and differences between diets in fatty acids
other than trans and cis monounsaturates were adjusted for using
regression coefficients from a meta-analysis of 27 controlled trials (1).
It would be uncommon for random fluctuations to produce an
effect in three independent trials. On the contrary, variability
might obscure the effect in a smaller trial with a lower dose,
which may have happened in the negative trial (5). A recent
Norwegian study also found that trans fatty acids from partially
hydrogenated fish or soybean oil elevated lipoprotein(a) con-
centrations relative to butter (1 1). Trans fatty acids therefore
appear to be one of the rare diet factors that influence lipopro-
tein(a) concentrations; however, the effect is modest compared
with genetically determined differences.
EPIDEMIOLOGIC STUDIES
When saturated fatty acids are replaced by trans fatty acids,
lipoprotein(a) goes up, HDL may be lowered, LDL changes little,
and serum triacylglycerol concentrations-not discussed much in
the report-also increase (12). It is this peculiar set of changes that
makes epidemiologic studies of trans fatty acids and coronary
disease of special interest. A weak point of such studies is that
consumption of foods high in trans fatty acids may form part of a
lifestyle that includes other factors affecting heart disease risk;
such confounding is difficult to eliminate. On the other hand, the
very crudeness of methods for measuring food intake should make
us pay attention when an association makes itself heard above the
noise. The poor precision of methods for determining intakes will
cause associations between diet and disease to appear weaker than
they are; this attenuation has in fact been the explanation for why
no associations are seen between saturated fat intake and coronary
heart disease within populations. The fact that the Nurses Health
Study and other studies find a positive association between trans
fatty acids and coronary heart disease therefore deserves attention.
By themselves such data fall far short of proving that high intakes
of trans fatty acids promote coronary heart disease, but the effects
of trans fatty acids on plasma lipids and lipoproteins lend some
credence to a causal link.
WHAT TO TELL THE CONSUMER?
For purposes of nutrition education I would favor summing
trans and saturated fatty acid contents of foods to a single
number. This avoids unnecessary emphasis on trans fatty acids,
which are after all a minor food component; it inhibits the
promotion of fats high in saturated fatty acids as replacements
for partially hydrogenated oils, which from a public health
point of view is undesirable; and it avoids sweeping assertions
about health effects of trans fatty acids.
I thank Ronald Mensink and Peter Zock for help and advice.
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